| The promoters of miR-9 precursors (mir-9-1, -2, and -3) were hypermethylated in cervical adenocarcinoma tissues; results present a tumor suppressor potential of miR-9 in cervical adenocarcinoma and suggest that miR-9 could repress tumorigenesis through inhibiting the activity of IL-6/Jak/STAT3 pathway. | cervical, |
| Comprehensive profiling of novel microRNA-9 targets and a tumor suppressor role of microRNA-9 via targeting IGF2BP1 in hepatocellular carcinoma | liver, |
| miR-9 might play a tumor suppressive role in oral squamous cell carcinoma and can serve as a promising biomarker for this deadly disease. | oral |
| Transcriptome profiling reveals miR-9-3p as a novel tumor suppressor in gastric cancer | gastric, |
| MicroRNA-9-5p functions as a tumor suppressor in papillary thyroid cancer via targeting BRAF | thyroid, |
| The evidence has been provided, that miR-9 is significantly downregulated in a subset of pediatric AML patients with high expression of EVI1, and that miR-9 has a critical role in EVI1-induced leukemogenesis in pediatric patients, thereby establishing the role of miR-9 as a tumor suppressor in the pathogenesis of EVI1-induced myeloid leukemia. | leukemia,pediatric, |
| MiR-9 functions as a tumor suppressor in acute myeloid leukemia by targeting CX chemokine receptor 4 | leukemia, |
| microRNA-9 functions as a tumor suppressor in colorectal cancer by targeting CXCR4 | colorectal, |
| miR-9 plays a role as a tumor suppressor in OSC by suppressing TLN1 expression. | None |
| microRNA-9 is a methylation-silenced tumour suppressor that could be a potential candidate predictive marker for poor prognosis of medulloblastoma. | None |
| MicroRNA-9 functions as a tumor suppressor and enhances radio-sensitivity in radio-resistant A549 cells by targeting neuropilin 1 | None |
| Biophysical simulations and structure-based modeling of residue interaction networks in the tumor suppressor proteins reveal functional role of cancer mutation hotspots in molecular communication | None |
| An oncogenic miR-9 targeted FoxO1 to promote cell growth; downregulation of this axis was involved in erlotinib_s cancer cells growth inhibitory effects. | None |